Abstract
New Zealand is a relative newcomer to the jurisdictions that have legalized medically assisted dying (AD) internationally. The End of Life Choice Act 2019 (the EOLC Act), in force since November 2021, permits a comparatively narrow scope of AD. It requires at least two medical practitioners to assess and determine a person's eligibility and establishes a range of legislative safeguards. Whilst the EOLC Act establishes several new statutory entities, it effectively, if not overtly, consigns overall responsibility for the operation of the AD system to the Registrar Assisted Dying (the Registrar), a new public office housed within the Ministry of Health. Whilst not legislatively mandated, a feature of New Zealand's AD service is the concurrently established funding regime to support equitable access.